A randomized controlled trial on medication-overuse headache: Outcome after 1 and 4 years

Acta Neurologica Scandinavica

Volumn 124, Issue SUPPL. 191, 2011, Pages 38-43

  Hagen, K ^a,b   Stovner, L J ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Medication overuse headache; Prospective study; Treatment

Indexed keywords

AMITRIPTYLINE; ANGIOTENSIN II ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GABAPENTIN; TOPIRAMATE; VALPROIC ACID;

ARTICLE; CONTROLLED STUDY; DETOXIFICATION; DRUG INDUCED HEADACHE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SHORT FORM 12;

EID: 79960053084     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2011.01542.x     Document Type: Article

References (27)

1. Diener HC, Limmroth L. Medication-overuse headache: a worldwide problem. Lancet Neurol 2004;3:475-83.
2. Rossi P, Jensen J, Nappi G, Allena M; The COMOESTAS Consortium. A narrative review on the management of medication overuse headache: the steep road from experience to evidence. J Headache Pain 2009;10:407-17.
3. Hagen K, Jensen R, Bøe MG, Stovner LJ. Medication overuse headache: a critical review of end points in recent follow-up studies. J Headache Pain 2010;11:373.
4. Headache Classification Committee of International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24(Suppl. 1):88-101.
5. Silberstein S, Olesen J, Bousser MG et al. The International Classification of Headache Disorders, 2nd Edition (ICHD-II) - revision of criteria for 8.2 Medication-overuse headache. Cephalalgia 2005;25:460-5.
6. Zeeberg P, Olesen J, Jensen R. Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology 2006;66:1894-8.
7. Hagen K, Albretsen C, Stovner LJ et al. Management of probable medication-overuse headache: 1-year randomized prospective multicenter trial. Cephalalgia 2008;29:221-32.
8. Headache Classification Committee, Olesen J, Bousser MG et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006;26:742-6.
9. Hagen K, Albretsen C, Stovner LJ et al. A 4-year follow-up of patients with medication-overuse headache previously included in a randomized multicentre study. J Headache Pain 2011;12:315-22.
10. Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 2007;27:814-23.
11. Dodick DW, Turkel CC, DeGryse RE et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 2010;50:921-36.
12. Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia 2006;26:1097-105.
13. Grande RB, Aaseth K, Benth JS, Lundquist C, Russell MB. Reduction in medication-overuse headache after short information. The Akerhus study of chronic headache. Eur J Neurol 2011;18:129-37.
14. Zeeberg P, Olesen J, Jensen R. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia 2006;26:1192-8.
15. Andrasik F, Grazzi L, Usai S, D'Amico D, Kass S, Bussone G. Disability in chronic migraine with medication overuse: treatment effects at 3years. Headache 2007;47:1277-81.
16. Bøe MG, Salvesen R, Mygland A. Chronic daily headache with medication overuse: a randomized follow-up by neurologist or PCP. Cephalalgia 2009;9:855-63.
17. Grazzi L, Andrasik F, Usai S, Bussone G. In-patient vs. day-hospital withdrawal treatment for chronic migraine with medication overuse and disability assessment: results at one-year follow-up. Neurol Sci 2008;29:S161-3.
18. Usai S, Grazzi L, D'Amico D, Andrasik F, Bussone G. Psychological variables chronic migraine with medication overuse before and after inpatient withdrawal: results at 1-year follow-up. Neurol Sci 2009;30:S125-7.
19. Andrasik F, Grazzi L, Usai S, Kass S, Bussone G. Disability in chronic migraine with medication overuse: treatment effects through 5years. Cephalalgia 2010;30:610-4.
20. Tribl GG, Schnider P, Wöber C et al. Are there predictive factors for long-term outcome after withdrawal in drug-induced chronic daily headache? Cephalalgia 2001;21:691-6.
21. Schnider P, Aull S, Baumgartner C et al. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up. Cephalalgia 1996;16:481-5.
22. Katsarava Z, Muessing M, Dzagnidze A, Fritche G, Diener HC, Limmroth V. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 2004;25:12-5.
23. Suhr B, Evers S, Bauer B, Gralow I, Grotemeyer KH, Husstedt IW. Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia 1999;19:44-9.
24. Pini LA, Ciero AFG, Sandrini M. Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia 2001;21:878-83.
25. Fontanillas N, Colás R, Muñoz P, Oterino A, Pascual J. Long-term evolution of chronic daily headache with medication overuse in the general population. Headache 2010;50:981-8.
26. Lyngberg AN, Rasmussen BK, Jørgensen T, Jensen R. Prognosis of migraine and tension-type headache. A population-based follow-up study. Neurology 2005;65:580-5.
27. Bøe MG, Salvesen R, Mygland A. Chronic daily headache with medication overuse: predictors of outcome 1year after withdrawal therapy. Eur J Neurol 2009;16:705-12.